Pfizer introduces antismoking drug in IndiaFebruary 26th, 2008 - 6:44 pm ICT by admin
Mumbai, Feb 26 (IANS) City-based $172-million Pfizer India Ltd, part of US pharmaceutical multinational Pfizer Inc, Tuesday launched the Varenicline prescription drug in India that helps smokers to kick their nicotine addiction. Varenicline, to be sold under the brand name Champix in India, is Pfizer’s hugely successful smoking cessation drug introduced in the US and Europe in 2006.
Unlike nicotine replacement therapies like nicotine patches or gum, Varenicline reduces cravings for nicotine and decreases the pleasurable effects of cigarettes and other tobacco products, which might help some addicts to kick the habit.
The company recommends a prescription course of 12 weeks for Varenicline, which will be available in 17 cities across India.
Speaking at the launch, Kewal Handa, managing director of Pfizer India, said: “Pfizer’s Champix is the most innovative and effective oral smoking cessation product to be approved by the US FDA (Food and Drug Administration) in the last 10 years.”
“It has benefited over 5.7 million people since its worldwide launch in mid-2006. We are confident that Champix will provide the same level of benefits to smokers in India and contribute to a healthier world,” he added.
Anjan Chatterjee, medical director of Pfizer India, said: “The holistic Champix therapy is designed to provide the necessary physiological and psychological support to the smoker.”
- Want to quit smoking? Get professional help - Jan 04, 2011
- Johnson & Johnson launches nicotine gum in India - Dec 20, 2010
- Johnson & Johnson launches nicotine gum in India (Lead) - Dec 20, 2010
- How anti-smoking drugs may curb cravings - Jan 04, 2011
- Personalized approach to smoking cessation may soon be a reality - Jul 03, 2010
- Quit-smoking drug 'instigates suicidal tendencies' - Aug 04, 2010
- Web, phone counseling may help smokers kick the butt - May 19, 2010
- Women smokers, hit the gym to curb nicotine craving - May 20, 2011
- Now a helpline to quit tobacco - May 29, 2012
- Smoking cessation drug 'does not increase self-harm or depression risk' - Oct 02, 2009
- Common anxiety disorders make it tougher to kick the butt - Oct 26, 2010
- Ciggie cravings result from habit, not addiction - Jul 14, 2010
- How second-hand smoke may increase vulnerability to nicotine addiction - May 03, 2011
- Brain imaging demonstrates that former smokers have greater willpower - Apr 27, 2011
- High drop-out rate hits Delhi's tobacco cessation centres - Jun 04, 2012
Tags: cessation product, champix, fda food, food and drug administration, india ltd, launch, medical director, nicotine, nicotine addiction, nicotine patches, nicotine replacement therapies, pfizer, pfizer inc, pfizer india, pleasurable effects, psychological support, smoking cessation, smoking cessation drug, tobacco products, varenicline